Society Letters

Endocrine Society Letter to Senators Warren and Blumenthal on Insulin Pricing

January 22, 2020

To: Senators Elizabeth Warren & Richard Blumenthal

"We were disappointed that your findings confirmed our concerns about access to affordable insulin as it had been our hope that new, lower cost alternatives and patient assistance programs were beginning to make a dent in this critical problem. We have been working with key stakeholders over the past two years to address this issue and requested information from manufacturers about the availability and use of lower cost options for people with diabetes. To us, it is not enough for these programs to be merely available; patient and clinician education must be expanded to ensure that individuals who desperately need access to lower cost insulin know and understand their options and have easy access to them."

arrow Read the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!